Ketamine Research and News
Ketamine for depression is an evolving field, and we strive to stay current on related literature and scientific studies. We’ve organized a comprehensive set of sources below, including medical society consensus statements, key systematic reviews, academic publications, popular news articles, and more.
Ketamine infusion therapy and efficacy for depression (Systematic Reviews and Meta-Analyses)
Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability, The Lancet 2023
Ketamine for the treatment of major depression: a systematic review and meta-analysis, eClinicalMedicine, 2023
The Role of Ketamine in the Treatment of Bipolar Depression, Brain Science 2023
Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions, Current Psychiatry Reports 2023
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis, Journal of Affective Disorders 2021
Societal consensus statements
The Management of Major Depressive Disorder, Annals of Internal Medicine 2022
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression, American Journal of Psychiatry 2021
Intravenous Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines, The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force, 2021
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders, JAMA Psychiatry 2017
Ketamine infusion therapy and efficacy for depression (Recent Clinical Trials)
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. New England Journal Of Medicine 2023
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression, Translational Psychiatry 2023
One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression, JAMA Network 2023
Intravenous Ketamine for Late-Life Treatment-Resistant Depression, American Journal of Geriatric Psychiatry 2023
Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression, Journal of Affective Disorder 2023
Ketamine drug properties and history
Ketamine Wikipedia Entry, Wikipedia
Ketamine Manufacturer Data Sheet, Pfizer
Ketamine - 50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms, Pharmacological Reports
Ketamine abuse
A review of the non-medical use of ketamine, Journal of Psychoactive Drugs
"The Ultimate Guide to Ketamine", The Third Wave (a harm reduction network)
DEA Fact Sheet on Ketamine, Drug Enforcement Agency
Ketamine for other mental health and wellness issues
Bipolar Disorder: Ketamine for bipolar depression: an updated systematic review, Therapeutic Advances in Psychopharmacology 2023
PTSD: The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses, Annals of Pharmacotherapy 2023
Suicidal Thoughts: Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review, Therapeutic Advances in Psychopharmacology 2023
Anxiety Disorders: Ketamine treatment for refractory anxiety: A systematic review, British Journal of Clinical Psychopharmacology 2022
Substance Abuse Disorder: Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review, Frontiers in Psychiatry 2018
Pain disorders: Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management, Regional Anesthesia and Pain Medicine 2018
Ketamine in popular news
The Harvard Gazette: Ketamine Matches 'Gold Standard' in Major Depression Trial
The New Yorker: Ketamine Therapy Is Going Mainstream. Are We Ready?
Elemental: Ketamine Is Revealing a New Understanding of Depression and the Brain
The New York Times: I Was Paralyzed by Severe Depression. Then Came Ketamine